21-Oct-15 GlaxoSmithKline's chief executive is joining a new panel to promote trade between Britain and China, just over a year after the drugmaker was handed a record fine of nearly USD500 mn (GBP323 mn ) for bribing Chinese doctors. The group has since been rebuilding its position in China. [image: Reuters / Luke Macgregor]

20-Oct-15 AstraZeneca announced a new state-of-the-art manufacturing and packaging facility in Kaluga, Russia, dedicated to the local supply of innovative medicines. In 2011 AstraZeneca was one of the first multinational pharmaceutical companies to announce plans to invest in the construction of a dedicated manufacturing facility in Russia. Four years on, the Company has invested USD224m. [image: AstraZeneca]

15-Oct-15 Japan's drug regulator, the Pharmaceuticals and Medical Devices Agency (PMDA), is set to open an India office soon. The move is expected to help Indian generic drug manufacturers, which have been seeking to increase their presence in Japan either through exports or by forging joint ventures with partners in that country. [image: The Economic Times]

15-Oct-15 Vetter, a global leader in aseptic manufacturing of drug-delivery systems, has announced a new business entity in Japan. As the second largest pharmaceutical single market, Japan is home to a number of leading global companies which offer a promising injectable pipeline. [image: Business Wire]

14-Oct-15 Indian drug retailers shut up shop for the day on Wednesday to protest against the country's growing online pharmacy industry, and threatened to close indefinitely if the government did not shut down e-pharmacies. The nationwide protest was supported by as many as 850,000 chemists, leaving patients waiting in long queues. [image: Reuters]